Drug interactions for the following drug(s)

Interactions between your selected drugs

Gabapentin enacarbil may increase the sedative activities of Pramipexole.

The risk or severity of adverse effects can be increased when Primidone is combined with Levodopa.

Primidone may increase the sedative activities of Pramipexole.

The risk or severity of adverse effects can be increased when Carisoprodol is combined with Levodopa.

The risk or severity of adverse effects can be increased when Valproic acid is combined with Gabapentin.

The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Primidone.

The risk or severity of adverse effects can be increased when Gabapentin is combined with Levodopa.

Gabapentin may increase the sedative activities of Pramipexole.

The risk or severity of adverse effects can be increased when Valproic acid is combined with Levodopa.

Carbidopa may decrease the excretion rate of Pramipexole which could result in a higher serum level.

gabapentin<>gabapentin enacarbil

Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule

The risk or severity of adverse effects can be increased when Gabapentin is combined with Gabapentin enacarbil.

Valproic acid may increase the sedative activities of Pramipexole.

The risk or severity of adverse effects can be increased when Carisoprodol is combined with Gabapentin.

The metabolism of Levothyroxine can be decreased when combined with Valproic acid.

The risk or severity of adverse effects can be increased when Carisoprodol is combined with Valproic acid.

The risk or severity of adverse effects can be increased when Primidone is combined with Gabapentin.

Carbidopa may decrease the excretion rate of Pramipexole which could result in a higher serum level.

The metabolism of Levothyroxine can be increased when combined with Primidone.

Carisoprodol may increase the sedative activities of Pramipexole.

The risk or severity of adverse effects can be increased when Carisoprodol is combined with Primidone.

The risk or severity of adverse effects can be increased when Valproic acid is combined with Gabapentin enacarbil.

Carbidopa may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.

The serum concentration of Phenobarbital, an active metabolite of Primidone, can be increased when used in combination with Valproic acid.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Interactions between your selected drugs

Drug1 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to pramipexole, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Pramipexole and Gabapentin enacarbil.

Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to levodopa, Drug2 is resolved to primidone and interaction asserted in DrugBank between Levodopa and Primidone.

Drug1 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to primidone, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Primidone and Pramipexole.

Drug1 (rxcui = 197446, name = carisoprodol 350 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to carisoprodol, Drug2 is resolved to levodopa and interaction asserted in DrugBank between Carisoprodol and Levodopa.

Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to valproate and interaction asserted in DrugBank between Gabapentin and Valproic acid.

Drug1 (rxcui = 308753, name = bisacodyl 5 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to bisacodyl, Drug2 is resolved to primidone and interaction asserted in DrugBank between Bisacodyl and Primidone.

Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to levodopa, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Levodopa and Gabapentin. Drug1 is resolved to levodopa, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Levodopa and Gabapentin enacarbil. Drug1 is resolved to carbidopa, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Carbidopa and Gabapentin enacarbil.

Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Gabapentin and Pramipexole.

Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to levodopa, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Levodopa and Valproic acid. Drug1 is resolved to levodopa, Drug2 is resolved to valproate and interaction asserted in DrugBank between Levodopa and Valproic acid.

Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to carbidopa, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Carbidopa and Pramipexole. Drug1 is resolved to levodopa, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Levodopa and Pramipexole.

gabapentin<>gabapentin enacarbil

Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule

Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Gabapentin and Gabapentin enacarbil. Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Gabapentin enacarbil and Gabapentin.

Drug1 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to valproate, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Valproic acid and Pramipexole. Drug1 is resolved to valproic acid, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Valproic acid and Pramipexole.

Drug1 (rxcui = 197446, name = carisoprodol 350 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to carisoprodol, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Carisoprodol and Gabapentin. Drug1 is resolved to carisoprodol, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Carisoprodol and Gabapentin enacarbil.

Drug1 (rxcui = 966232, name = levothyroxine sodium 0.088 MG Oral Tablet [Unithroid], tty = SBD). Drug2 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to valproate and interaction asserted in DrugBank between Levothyroxine and Valproic acid. Drug1 is resolved to levothyroxine, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Levothyroxine and Valproic acid.

Drug1 (rxcui = 197446, name = carisoprodol 350 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to carisoprodol, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Carisoprodol and Valproic acid. Drug1 is resolved to carisoprodol, Drug2 is resolved to valproate and interaction asserted in DrugBank between Carisoprodol and Valproic acid.

Drug1 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to primidone, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Primidone and Gabapentin. Drug1 is resolved to primidone, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Primidone and Gabapentin enacarbil.

Drug1 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to pramipexole, Drug2 is resolved to carbidopa anhydrous and interaction asserted in DrugBank between Pramipexole and Carbidopa.

Drug1 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966232, name = levothyroxine sodium 0.088 MG Oral Tablet [Unithroid], tty = SBD). Drug1 is resolved to primidone, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Primidone and Levothyroxine.

Drug1 (rxcui = 197446, name = carisoprodol 350 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to carisoprodol, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Carisoprodol and Pramipexole.

Drug1 (rxcui = 197446, name = carisoprodol 350 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to carisoprodol, Drug2 is resolved to primidone and interaction asserted in DrugBank between Carisoprodol and Primidone.

Drug1 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to valproate, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Valproic acid and Gabapentin enacarbil. Drug1 is resolved to valproic acid, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Valproic acid and Gabapentin. Drug1 is resolved to valproic acid, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Valproic acid and Gabapentin enacarbil.

Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to carbidopa anhydrous and interaction asserted in DrugBank between Gabapentin enacarbil and Carbidopa.

Drug1 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to primidone, Drug2 is resolved to valproate and interaction asserted in DrugBank between Primidone and Valproic acid. Drug1 is resolved to primidone, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Primidone and Valproic acid.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.